humanized antibody (ABBA Therapeutics)

N/A

Report date: 2026/03/19 16:57:38

Base Information

Drug Namehumanized antibody (ABBA Therapeutics)

Drug Alias Nameanti-CD3/anti-survivin/anti-albumin trispecific T-cell engager (AbbVie/Harpoon)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAntibacterial multidrug resistance inhibitorsAnti-CD3

TargetsT cell surface glycoprotein CD3

Therapy Area/IndicationsMultidrug-Resistant InfectionSkin Diseases, BacterialGram-Negative Bacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsYes

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Cincinnati

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArch Biopartners Inc

Active IndicationsN/A

Inactive IndicationsMultidrug-Resistant InfectionSkin Diseases, BacterialGram-Negative Bacterial Infections

Other Information

ATC CodeN/A